European Archives - Page 1054 of 1134 - European Medical Journal

EMJ

Eczema Successfully Treated with Arthritis Therapy

ARTHRITIS drug could transform the treatment of eczema, for which there is currently no targeted therapy, according to researchers who showed…

EMJ

Genomic profiling for defining luminal subtypes

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Harold J. Burstein, MD, PhD, of Dana-Farber Cancer Institute, Boston, MA…

EMJ

Using genomic testing to access the suitability of breast cancer patients for chemotherapy

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph Gligorov, MD, PhD, of Sorbonne Université, Paris, France, discusses the…

EMJ

Plans for Universal Flu Vaccine Receive Timely Boost

DREAMS of a universal flu vaccine that is effective against all flu strains are a step closer to becoming a reality thanks to the findings of a new study.

EMJ

High-Fibre Diet During Pregnancy May Guard Offspring Against Asthma

WOMEN who consume a high-fibre diet during pregnancy may reduce the risk of their offspring developing asthma, according to new study data.

EMJ

CardioSecur: 22-Lead Mobile ECG Enables 360-Degree View of the Heart

London (28.08.2015). Personal MedSystems introduces the first and only 22-lead mobile ECG system, CardioSecur, at the European Society of Cardiology…

EMJ

Siemens Solutions Support Diagnosis and Treatment of Cardiovascular Diseases

Cardiovascular diseases such as heart attack, stroke, and coronary heart disease have been among the most common causes of death worldwide for many years…

EMJ

PTSD in Vietnam War Veterans Reveals Lifelong Impact of Combat Service

AMERICAN veterans of the Vietnam War continue to experience post-traumatic stress disorder (PTSD) and other mental health illnesses despite…

EMJ

Schizophrenia: Identification of ‘Rosetta Stone’ Gene

DISCOVERY of a key role for the protein ‘disrupted in schizophrenia 1’ (DISC1) during a critical period of neural development shortly after birth may…

EMJ

Janssen Submits European Extension Marketing Authorisation Application for Paliperidone Palmitate Once-Every-Three-Months Formulation

BEERSE, Belgium, 21st August 2015 – Janssen-Cilag International NV (Janssen) today announced the submission of an Extension Marketing Authorisation…